Provided by Tiger Trade Technology Pte. Ltd.

CSPC PHARMA

9.170
+0.3203.62%
Volume:21.56M
Turnover:195.82M
Market Cap:105.66B
PE:23.03
High:9.235
Open:8.900
Low:8.870
Close:8.850
52wk High:10.720
52wk Low:6.387
Shares:11.52B
HK Float Shares:11.52B
Volume Ratio:2.64
T/O Rate:0.19%
Dividend:0.34
Dividend Rate:3.69%
EPS(LYR):0.398
ROE:20.90%
ROA:10.70%
PB:2.40
PE(LYR):23.03
PS:2.88

Loading ...

CSPC Pharmaceutical Group Stock Falls 1.3% in Hong Kong, Underperforms Competitors

Dow Jones
·
Aug 05

CSPC Pharma, AstraZeneca Form Biologics Manufacturing JV in China with 51%-49% Split

Reuters
·
Aug 05

CSPC Pharmaceutical - Co to Hold 51% and AstraZeneca 49% in Joint Venture

THOMSON REUTERS
·
Aug 05

CSPC Pharmaceutical - Joint Venture to Manufacture Biologics Drug Substances for Global Markets

THOMSON REUTERS
·
Aug 05

CSPC Pharma Unit, Alphamab Oncology's Breast Cancer Drug Application Granted Priority Review in China

MT Newswires Live
·
Aug 04

CSPC Says NMPA Accepts NDA for Anbenitamab, Albumin-Bound Docetaxel Neoadjuvant Breast Cancer Combo Under Priority Review

Reuters
·
Aug 04

Alphamab Oncology Says NMPA Accepts NDA for Anbenitamab (kn026)

Reuters
·
Aug 04

CSPC Pharma Begins Phase Ib/II Trial of Colorectal Cancer Drug Candidate

MT Newswires Live
·
Aug 03

CSPC Pharmaceutical - Initiates Phase Ib/Ii Trial of Sys 6090 Injection for Colorectal Cancer in China

THOMSON REUTERS
·
Aug 03

CSPC Pharmaceutical Group Stock Falls 1.3% in Hong Kong

Dow Jones
·
Aug 03

Movement Alert|CSPC PHARMA Falls 3.03% in Regular Trading, Trading at HK$8.31

Market Focus
·
Aug 03

CSPC Pharma Wins China Trial Approval for RSV Vaccine

MT Newswires Live
·
Aug 03

CSPC Pharmaceutical Group's SYS6041 Combination Therapy Phase II Trial for Recurrent Ovarian Cancer Has Officially Launched at the First Center in China

Stock News
·
Jul 31

CSPC Pharma Secures NMPA Clearance to Begin Clinical Trials for Second Recombinant RSV Vaccine

Bulletin Express
·
Jul 31

CSPC Pharma Says China Clears Clinical Trial for RSV Vaccine Candidate SYS 6057

Reuters
·
Jul 31

CSPC Pharmaceutical - Pharma's Recombinant Rsv Vaccine (Sys6057) Obtains Clinical Trial Approval in China

THOMSON REUTERS
·
Jul 31

CSPC Pharma Ramps up Usd/rmb Hedging with FX Swap, Forwards Totaling USD 344 Million

Reuters
·
Jul 30

CSPC Pharmaceutical - Unit Enters FX Swap and FX Forward Contracts with Icbc Since June 16, 2026

THOMSON REUTERS
·
Jul 30

CSPC Pharmaceutical - Zhongqi to Place USD 3.19 Mln Security Deposit for FX Swap Contract

THOMSON REUTERS
·
Jul 30

CSPC Pharmaceutical Starts Phase 2 Trial of Hypertension Drug

MT Newswires Live
·
Jul 30